| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial
|
Bui-Nguyen, B.
|
|
2015
|
51 |
10 |
p. 1312-1320
9 p.
|
artikel
|
| 2 |
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients
|
Powles, Thomas
|
|
2015
|
51 |
10 |
p. 1293-1302
10 p.
|
artikel
|
| 3 |
Childhood height increases the risk of prostate cancer mortality
|
Aarestrup, J.
|
|
2015
|
51 |
10 |
p. 1340-1345
6 p.
|
artikel
|
| 4 |
Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trial
|
Nishimura, Junichi
|
|
2015
|
51 |
10 |
p. 1274-1282
9 p.
|
artikel
|
| 5 |
Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients
|
Cho, Jae-Keun
|
|
2015
|
51 |
10 |
p. 1303-1311
9 p.
|
artikel
|
| 6 |
Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopies
|
Brenner, Hermann
|
|
2015
|
51 |
10 |
p. 1346-1353
8 p.
|
artikel
|
| 7 |
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer
|
Bokemeyer, C.
|
|
2015
|
51 |
10 |
p. 1243-1252
10 p.
|
artikel
|
| 8 |
Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08
|
Zaman, Khalil
|
|
2015
|
51 |
10 |
p. 1212-1220
9 p.
|
artikel
|
| 9 |
Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer
|
Douillard, Jean-Yves
|
|
2015
|
51 |
10 |
p. 1231-1242
12 p.
|
artikel
|
| 10 |
Old age as risk indicator for poor end-of-life care quality – A population-based study of cancer deaths from the Swedish Register of Palliative Care
|
Lindskog, Magnus
|
|
2015
|
51 |
10 |
p. 1331-1339
9 p.
|
artikel
|
| 11 |
Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
|
Dilz, Lisa-Marie
|
|
2015
|
51 |
10 |
p. 1253-1262
10 p.
|
artikel
|
| 12 |
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study
|
Thomsen, Frederik B.
|
|
2015
|
51 |
10 |
p. 1283-1292
10 p.
|
artikel
|
| 13 |
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care
|
Hjorth, Lars
|
|
2015
|
51 |
10 |
p. 1203-1211
9 p.
|
artikel
|
| 14 |
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
|
Dirven, Linda
|
|
2015
|
51 |
10 |
p. 1321-1330
10 p.
|
artikel
|
| 15 |
Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: Results from the population-based PROFILES registry
|
Verhaar, Simone
|
|
2015
|
51 |
10 |
p. 1263-1273
11 p.
|
artikel
|
| 16 |
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysis
|
Kiderlen, Mandy
|
|
2015
|
51 |
10 |
p. 1221-1230
10 p.
|
artikel
|
Tijdschrift beschrijving